"Rifkind and Freeman's account serves as an introduction for the general reader to microbiology, immunology and infectious diseases...There are also some interesting points for the specialist."- Robin A. Weiss, University College London for NATURE MEDICINE (June 2006)"...unique features are the introduction and the counterpoint sections that provoke reader thought regarding the never-ending process of scientific pursuit, and future candidates for Nobel Prizes."- DOODY'S (3 Stars) 2006

• Part A: ImmunityIntroduction to Part A: IMMUNITYChapter 1: SEROTHERAPYChapter 2: ANTIMICROBIAL DEFENSESChapter 3: MHC RESTRICTIONPart B: AntimicrobialsIntroduction to Part B: ANTIMICROBIALSChapter 4: PRONTOSIL AND THE SULFONAMIDESChapter 5: PENICILLINChapter 6: STREPTOMYCINChapter 7: CHEMOTHERAPEUTIC AGENTSPart C: BacteriaIntroduction to Part C: BACTERIAChapter 8: TUBERCULOSISChapter 9: TYPHUSChapter 10: SYPHILIS THERAPYPart D: VirusesIntroduction to Part D: VIRUSESChapter 11: TOBACCO MOSAIC VIRUSChapter 12: YELLOW FEVERChapter 13: POLIOMYELITIS VIRUSChapter 14: HEPATITIS B VIRUSChapter 15: BACTERIOPHAGEChapter 16: BACTERIOPHAGE LYSOGENYChapter 17: ROUS SARCOMA VIRUSChapter 18: POLYOMA VIRUSChapter 19: REVERSE TRANSCRIPTASEChapter 20: VIRAL ONCOGENESChapter 21: KURUChapter 22: PRIONSPart E: ParasitesIntroduction to Part E: PARASITESChapter 23: MALARIAChapter 24: CANCER PARASITEChapter 25: DDTCOUNTERPOINT: HIV/AIDSINDEX

"Rifkind and Freeman's account serves as an introduction for the general reader to microbiology, immunology and infectious diseases...There are also some interesting points for the specialist."- Robin A. Weiss, University College London for NATURE MEDICINE (June 2006)"...unique features are the introduction and the counterpoint sections that provoke reader thought regarding the never-ending process of scientific pursuit, and future candidates for Nobel Prizes."- DOODY'S (3 Stars) 2006

• Part A: ImmunityIntroduction to Part A: IMMUNITYChapter 1: SEROTHERAPYChapter 2: ANTIMICROBIAL DEFENSESChapter 3: MHC RESTRICTIONPart B: AntimicrobialsIntroduction to Part B: ANTIMICROBIALSChapter 4: PRONTOSIL AND THE SULFONAMIDESChapter 5: PENICILLINChapter 6: STREPTOMYCINChapter 7: CHEMOTHERAPEUTIC AGENTSPart C: BacteriaIntroduction to Part C: BACTERIAChapter 8: TUBERCULOSISChapter 9: TYPHUSChapter 10: SYPHILIS THERAPYPart D: VirusesIntroduction to Part D: VIRUSESChapter 11: TOBACCO MOSAIC VIRUSChapter 12: YELLOW FEVERChapter 13: POLIOMYELITIS VIRUSChapter 14: HEPATITIS B VIRUSChapter 15: BACTERIOPHAGEChapter 16: BACTERIOPHAGE LYSOGENYChapter 17: ROUS SARCOMA VIRUSChapter 18: POLYOMA VIRUSChapter 19: REVERSE TRANSCRIPTASEChapter 20: VIRAL ONCOGENESChapter 21: KURUChapter 22: PRIONSPart E: ParasitesIntroduction to Part E: PARASITESChapter 23: MALARIAChapter 24: CANCER PARASITEChapter 25: DDTCOUNTERPOINT: HIV/AIDSINDEX